Health Condition 1: E888- Other specified metabolic disorders
Conditions
Interventions
Control Intervention1: Nil: Nil
Sponsors
Humors Tech Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Apparently healthy individuals for phase I Diabetes, liver, renal and metabolic derangements for phase II of study. 2.Age group 18-60 years. 3.Completed 2 doses of COVID vaccination. 4.Willing to give written informed consent.
Exclusion criteria
Exclusion criteria: 1.Pregnant and lactating females. 2.Known case of any chronic illness- Cancer, AIDS, COVID, Tuberculosis 3.History of any acute infection- respiratory tract infections. 4.Haemo-dynamically unstable critically ill intensive care unit patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of bio-markers- Acetone Benzene,Toulene,Hydrogen, Carbon Monoxide,Ammonia,Ethanol Hydrogen Sulfide, Butane and Methane in breath sample and Development of Artificial Intelligence (AI) based affordable non-invasive device for accurate early screening of diabetes, liver, renal and metabolic function derangements by comparing values measured by breath analyzer device with blood levels of fasting, PPBS, LFT parameters and RFT parameters. Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of Total Cholesterol Triglycerides HDL VLDL LDL Cholesterol/ HDL Ratio LDL/HDL Ratio and compare with levels of critical compounds measured by breath analyzer device.Timepoint: 1 year | — |
Countries
India
Contacts
Public ContactDr Tribhuwan Kumar
AIIMS Patna
Outcome results
None listed